Integrated Advisors Network’s Regeneron Pharmaceuticals REGN Stock Holding History

Integrated Advisors Network’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-828	Closed	-$639K	–	740
2026 Q1	$639K	Buy	+828	New	+$634K	0.03%	415
2024 Q4	–	Sell	-197	Closed	-$207K	–	750
2024 Q3	$207K	Sell	197 -11	-5%	-$12.2K	0.01%	682
2024 Q2	$218K	Sell	208 -3	-1%	-$2.91K	0.01%	642
2024 Q1	$203K	Sell	211 -46	-18%	-$43.7K	0.01%	685
2023 Q4	$225K	Sell	257 -17	-6%	-$14K	0.01%	615
2023 Q3	$225K	Buy	+274	New	+$215K	0.01%	603
2023 Q2	–	Sell	-260	Closed	-$213K	–	703
2023 Q1	$213K	Buy	+260	New	+$196K	0.01%	615
2020 Q4	–	Sell	-1,121	Closed	-$628K	–	514
2020 Q3	$628K	Buy	1,121 +545	+95%	+$330K	0.08%	223
2020 Q2	$359K	Buy	+576	New	+$327K	0.04%	309

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Integrated Advisors Network's REGN Position: Q2 2026 in Review

Integrated Advisors Network sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 828 shares — an estimated $639K sold.

Integrated Advisors Network first reported a position in REGN in Q2 2020 and held it in 9 quarters. The position peaked at $639K in Q1 2026. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Integrated Advisors Network reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Integrated Advisors Network sold 828 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $639K.
Integrated Advisors Network first reported a position in Regeneron Pharmaceuticals in Q2 2020 and held it in 9 quarters.
Integrated Advisors Network's Regeneron Pharmaceuticals position peaked at $639K in Q1 2026.
1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Integrated Advisors Network's 13F filing for Q2 2026, filed 11 Aug 2026.